Definium Therapeutics (DFTX) Operating Expenses (2021 - 2026)
Definium Therapeutics (DFTX) posted quarterly Operating Expenses of $59.2 million for Q1 2026, up 84.15% year-over-year from $32.2 million in Q1 2025, and up 24.47% quarter-over-quarter from $47.6 million in Q4 2025.
Definium Therapeutics (DFTX) Operating Expenses (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported Operating Expenses for 6 consecutive years, with $59.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 84.15% year-over-year to $59.2 million; the TTM figure through Mar 2026 stood at $193.4 million (up 69.81% YoY), while the FY2025 annual figure was $166.3 million, up 60.04% from the prior year.
- Operating Expenses advanced to $59.2 million in Q1 2026 per DFTX's latest filing, from $47.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $59.2 million in Q1 2026 and bottomed at $13.9 million in Q4 2022.
- Historically, Operating Expenses has averaged $28.8 million across 5 years, with a median of $24.5 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses slumped 62.53% — and 2025, when it soared 84.21%.
- Definium Therapeutics' Operating Expenses stood at $13.9 million in 2022, then soared by 59.75% to $22.2 million in 2023, then soared by 46.19% to $32.5 million in 2024, then surged by 46.57% to $47.6 million in 2025, then advanced by 24.47% to $59.2 million in 2026.
- Business Quant data shows DFTX's Operating Expenses at $59.2 million in Q1 2026, $47.6 million in Q4 2025, and $45.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Definium Therapeutics | 4.72 Bn | 4.72 Bn | - | 75.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.08 Mn |
| Mar 31, 2026 | 59.22 Mn |
| Dec 31, 2025 | 47.58 Mn |
| Sep 30, 2025 | 45.67 Mn |
| Jun 30, 2025 | 40.90 Mn |
| Mar 31, 2025 | 32.16 Mn |
| Dec 31, 2024 | 32.46 Mn |
| Sep 30, 2024 | 24.79 Mn |
| Jun 30, 2024 | 24.46 Mn |
| Mar 31, 2024 | 22.20 Mn |
| Dec 31, 2023 | 22.21 Mn |
| Sep 30, 2023 | 21.62 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Mar 31, 2023 | 20.86 Mn |
| Dec 31, 2022 | 13.90 Mn |
| Sep 30, 2022 | 16.98 Mn |
| Jun 30, 2022 | 16.94 Mn |
| Mar 31, 2022 | 18.51 Mn |
| Dec 31, 2021 | 17.56 Mn |
| Sep 30, 2021 | 17.23 Mn |